![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DOCK11 |
Gene summary for DOCK11 |
![]() |
Gene information | Species | Human | Gene symbol | DOCK11 | Gene ID | 139818 |
Gene name | dedicator of cytokinesis 11 | |
Gene Alias | ACG | |
Cytomap | Xq24 | |
Gene Type | protein-coding | GO ID | GO:0001775 | UniProtAcc | Q5JSL3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
139818 | DOCK11 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.12e-09 | 3.05e-01 | -0.1464 |
139818 | DOCK11 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.97e-02 | 9.02e-02 | -0.1001 |
139818 | DOCK11 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.08e-03 | 1.82e-01 | -0.059 |
139818 | DOCK11 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 5.43e-09 | 5.03e-01 | 0.281 |
139818 | DOCK11 | A001-C-119 | Human | Colorectum | FAP | 1.92e-02 | 4.08e-01 | -0.1557 |
139818 | DOCK11 | A002-C-021 | Human | Colorectum | FAP | 2.06e-05 | 3.64e-01 | 0.1171 |
139818 | DOCK11 | male-WTA | Human | Thyroid | PTC | 5.45e-21 | 1.74e-01 | 0.1037 |
139818 | DOCK11 | PTC01 | Human | Thyroid | PTC | 4.13e-12 | 2.04e-01 | 0.1899 |
139818 | DOCK11 | PTC04 | Human | Thyroid | PTC | 6.06e-12 | 2.53e-01 | 0.1927 |
139818 | DOCK11 | PTC05 | Human | Thyroid | PTC | 6.45e-18 | 5.92e-01 | 0.2065 |
139818 | DOCK11 | PTC06 | Human | Thyroid | PTC | 4.28e-41 | 8.09e-01 | 0.2057 |
139818 | DOCK11 | PTC07 | Human | Thyroid | PTC | 8.30e-18 | 3.14e-01 | 0.2044 |
139818 | DOCK11 | ATC12 | Human | Thyroid | ATC | 1.25e-15 | 3.16e-01 | 0.34 |
139818 | DOCK11 | ATC13 | Human | Thyroid | ATC | 1.27e-28 | 5.07e-01 | 0.34 |
139818 | DOCK11 | ATC2 | Human | Thyroid | ATC | 2.37e-04 | 3.12e-01 | 0.34 |
139818 | DOCK11 | ATC4 | Human | Thyroid | ATC | 1.22e-19 | 4.18e-01 | 0.34 |
139818 | DOCK11 | ATC5 | Human | Thyroid | ATC | 2.97e-27 | 5.54e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0043087 | Colorectum | AD | regulation of GTPase activity | 110/3918 | 348/18723 | 1.64e-06 | 5.03e-05 | 110 |
GO:0048872 | Colorectum | AD | homeostasis of number of cells | 87/3918 | 272/18723 | 1.16e-05 | 2.61e-04 | 87 |
GO:0031346 | Colorectum | AD | positive regulation of cell projection organization | 104/3918 | 353/18723 | 8.26e-05 | 1.30e-03 | 104 |
GO:0043547 | Colorectum | AD | positive regulation of GTPase activity | 75/3918 | 255/18723 | 7.95e-04 | 7.91e-03 | 75 |
GO:0001782 | Colorectum | AD | B cell homeostasis | 13/3918 | 31/18723 | 6.53e-03 | 4.06e-02 | 13 |
GO:0120034 | Colorectum | AD | positive regulation of plasma membrane bounded cell projection assembly | 33/3918 | 105/18723 | 7.49e-03 | 4.55e-02 | 33 |
GO:0120032 | Colorectum | AD | regulation of plasma membrane bounded cell projection assembly | 53/3918 | 186/18723 | 8.51e-03 | 4.97e-02 | 53 |
GO:00430872 | Colorectum | MSS | regulation of GTPase activity | 101/3467 | 348/18723 | 1.00e-06 | 3.46e-05 | 101 |
GO:00488722 | Colorectum | MSS | homeostasis of number of cells | 82/3467 | 272/18723 | 2.02e-06 | 6.28e-05 | 82 |
GO:00313462 | Colorectum | MSS | positive regulation of cell projection organization | 96/3467 | 353/18723 | 3.44e-05 | 6.70e-04 | 96 |
GO:00435471 | Colorectum | MSS | positive regulation of GTPase activity | 68/3467 | 255/18723 | 7.97e-04 | 8.38e-03 | 68 |
GO:01200322 | Colorectum | MSS | regulation of plasma membrane bounded cell projection assembly | 51/3467 | 186/18723 | 1.78e-03 | 1.58e-02 | 51 |
GO:00604911 | Colorectum | MSS | regulation of cell projection assembly | 51/3467 | 188/18723 | 2.28e-03 | 1.87e-02 | 51 |
GO:00017821 | Colorectum | MSS | B cell homeostasis | 12/3467 | 31/18723 | 6.80e-03 | 4.39e-02 | 12 |
GO:01200341 | Colorectum | MSS | positive regulation of plasma membrane bounded cell projection assembly | 30/3467 | 105/18723 | 7.74e-03 | 4.84e-02 | 30 |
GO:00430873 | Colorectum | FAP | regulation of GTPase activity | 85/2622 | 348/18723 | 1.20e-07 | 7.68e-06 | 85 |
GO:00313463 | Colorectum | FAP | positive regulation of cell projection organization | 82/2622 | 353/18723 | 1.78e-06 | 7.35e-05 | 82 |
GO:00435472 | Colorectum | FAP | positive regulation of GTPase activity | 61/2622 | 255/18723 | 1.39e-05 | 3.73e-04 | 61 |
GO:00488724 | Colorectum | FAP | homeostasis of number of cells | 60/2622 | 272/18723 | 1.91e-04 | 2.79e-03 | 60 |
GO:1903131 | Colorectum | FAP | mononuclear cell differentiation | 79/2622 | 426/18723 | 5.00e-03 | 3.33e-02 | 79 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DOCK11 | SNV | Missense_Mutation | c.2654N>T | p.Glu885Val | p.E885V | Q5JSL3 | protein_coding | tolerated(0.06) | possibly_damaging(0.635) | TCGA-EK-A2RB-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
DOCK11 | SNV | Missense_Mutation | c.5243A>C | p.Lys1748Thr | p.K1748T | Q5JSL3 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
DOCK11 | SNV | Missense_Mutation | c.1624C>G | p.Leu542Val | p.L542V | Q5JSL3 | protein_coding | tolerated(0.18) | possibly_damaging(0.751) | TCGA-IR-A3LH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
DOCK11 | SNV | Missense_Mutation | c.4529N>C | p.Arg1510Thr | p.R1510T | Q5JSL3 | protein_coding | deleterious(0) | possibly_damaging(0.889) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
DOCK11 | SNV | Missense_Mutation | c.2368N>A | p.Asp790Asn | p.D790N | Q5JSL3 | protein_coding | tolerated(0.18) | benign(0.021) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
DOCK11 | SNV | Missense_Mutation | c.3155N>T | p.Ser1052Phe | p.S1052F | Q5JSL3 | protein_coding | deleterious(0) | possibly_damaging(0.862) | TCGA-LP-A5U2-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | |
DOCK11 | SNV | Missense_Mutation | novel | c.5563N>C | p.Glu1855Gln | p.E1855Q | Q5JSL3 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-MA-AA3Y-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
DOCK11 | SNV | Missense_Mutation | c.6040N>C | p.Glu2014Gln | p.E2014Q | Q5JSL3 | protein_coding | deleterious(0) | probably_damaging(0.947) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
DOCK11 | SNV | Missense_Mutation | c.673N>A | p.Ala225Thr | p.A225T | Q5JSL3 | protein_coding | tolerated(0.35) | possibly_damaging(0.557) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
DOCK11 | SNV | Missense_Mutation | c.1238N>T | p.Ala413Val | p.A413V | Q5JSL3 | protein_coding | deleterious(0.02) | probably_damaging(0.928) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |